enGene Therapeutics Inc. (ENGNW) Operating cash flow 2022–2025
enGene Therapeutics Inc. (ENGNW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$99.2MFY2025 · since FY2022: -$17.6M → -$99.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$99.2M | -105.5% |
| FY2024 | -$48.3M | -95.1% |
| FY2023 | -$24.7M | -40.6% |
| FY2022 | -$17.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice